Vivace Formalizes Leadership Ahead of Phase III
Vivace Therapeutics named Craig Gibbs as chief executive officer and appointed Ellen Lubman as chief business and strategy officer, formalizing a leadership transition from founder Sofie Qiao as the company advances VT3989 toward a…
